Korean J Otolaryngol-Head Neck Surg.  2004 Feb;47(2):103-107.

Expression of beta Defensins in the Human Middle Ear Mucosa

Affiliations
  • 1Department of Otolaryngology, Ajou University School of Medicine, Suwon, Korea. smoon@ajou.ac.kr
  • 2Gonda Department of Cell & Molecular Biology, House Ear Institute, LA, USA.

Abstract

BACKGROUND AND OBJECTIVES
It is believed that the innate immunity plays a critical role in protecting the tubotympanum from being infected because the middle ear cavity is normally sterile despite of a paucity of immune cells. Among known antibacterial molecules, defensins have been shown to contribute significantly to innate immunity. However, it is still unclear whether or not beta defensins are expressed in human middle ear mucosa. MATERIALS AND METHOD: Immunolabeling and RT-PCR were performed with the mucosal specimen from normal subjects and otitis media patients, respectively. Expression of beta defensin 2 mRNA was compared between the control group and experimental group that was treated by inflammatory stimuli in the animal models using RT-PCR. RESULTS: beta defensin 1 was expressed in both normal and inflamed middle ear mucosa of human, but beta defensin 2 and 3 were found only in the inflamed mucosa. The expression of beta defensin 2 mRNA was up-regulated when the interleukin-1alpha (IL-1alpha) or lipopolysaccharide (LPS) was treated in the middle ear mucosa of the experimental animals. CONCLUSION: We could show that beta defensins are expressed in the human middle ear mucosa and that beta defensin 2 is up-regulated by the inflammatory stimuli, IL-1alpha or LPS.

Keyword

Defensins; Middle ear; Otitis media

MeSH Terms

Animals
beta-Defensins*
Defensins
Ear, Middle*
Humans*
Immunity, Innate
Interleukin-1alpha
Models, Animal
Mucous Membrane*
Otitis Media
RNA, Messenger
Defensins
Interleukin-1alpha
RNA, Messenger
beta-Defensins
Full Text Links
  • KJORL-HN
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr